Skip to main content
Erschienen in: European Radiology 3/2018

06.10.2017 | Magnetic Resonance

Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method

verfasst von: Ji Soo Song, Eun Jung Choi, Eun Hae Park, Ju-Hyung Lee

Erschienen in: European Radiology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare the occurrence of transient severe motion (TSM) between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI and between gadoxetate disodium-enhanced MRI scans obtained with and without the application of a modified breath-holding technique.

Methods

We reviewed 80 patients who underwent two magnetic resonance examinations (gadoxetate disodium-enhanced MRI and gadopentetate dimeglumine-enhanced MRI) with the application of a modified breath-holding technique (dual group). This group was compared with 100 patients who underwent gadoxetate disodium-enhanced MRI without the application of the modified breath-holding technique (single group). Patient risk factors and motion scores (1 [none] to 5 [non-diagnostic]) for each dynamic-phase imaging were analysed.

Results

In the dual group, mean motion scores did not differ significantly between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI (p=0.096–0.807) in any phase. However, in all phases except the late dynamic phase, mean motion scores of the dual group were significantly lower than those in the single group. TSM incidence did not differ significantly between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI in the dual group (3.8% vs. 1.3%, p=0.620).

Conclusion

With proper application of the modified breath-holding technique, TSM occurrence with gadoxetate disodium-enhanced MRI was comparable to that associated with gadopentetate dimeglumine-enhanced MRI.

Key Points

The modified breath-holding method significantly reduced the incidence of TSM.
Gadoxetate disodium and gadopentetate dimeglumine showed comparable motion scores.
TSM incidence was comparable between gadoxetate disodium- and gadopentetate dimeglumine-enhanced MRI.
Literatur
1.
Zurück zum Zitat Bashir MR, Gupta RT, Davenport MS, Allen BC, Jaffe TA, Ho LM et al (2013) Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging 37:398–406CrossRefPubMed Bashir MR, Gupta RT, Davenport MS, Allen BC, Jaffe TA, Ho LM et al (2013) Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging 37:398–406CrossRefPubMed
2.
Zurück zum Zitat Chung YE, Kim MJ, Kim YE, Park MS, Choi JY, Kim KW (2013) Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One 8:e66141CrossRefPubMedPubMedCentral Chung YE, Kim MJ, Kim YE, Park MS, Choi JY, Kim KW (2013) Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One 8:e66141CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K et al (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34:326–335CrossRefPubMed Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K et al (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34:326–335CrossRefPubMed
4.
Zurück zum Zitat Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529CrossRefPubMed Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529CrossRefPubMed
5.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635–654CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635–654CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Frydrychowicz A, Nagle SK, D'Souza SL, Vigen KK, Reeder SB (2011) Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 34:585–594CrossRefPubMedPubMedCentral Frydrychowicz A, Nagle SK, D'Souza SL, Vigen KK, Reeder SB (2011) Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 34:585–594CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748CrossRefPubMed Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748CrossRefPubMed
9.
Zurück zum Zitat Schmid-Tannwald C, Herrmann K, Oto A, Panteleon A, Reiser M, Zech C (2012) Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate. Acta Radiol 53:961–965CrossRefPubMed Schmid-Tannwald C, Herrmann K, Oto A, Panteleon A, Reiser M, Zech C (2012) Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate. Acta Radiol 53:961–965CrossRefPubMed
10.
Zurück zum Zitat Tamada T, Ito K, Yoshida K, Kanki A, Higaki A, Tanimoto D et al (2011) Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver. Eur J Radiol 80:e284–e288CrossRefPubMed Tamada T, Ito K, Yoshida K, Kanki A, Higaki A, Tanimoto D et al (2011) Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver. Eur J Radiol 80:e284–e288CrossRefPubMed
11.
Zurück zum Zitat Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A et al (2011) Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 46:141–145CrossRefPubMed Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A et al (2011) Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 46:141–145CrossRefPubMed
12.
Zurück zum Zitat Davenport MS, Caoili EM, Kaza RK, Hussain HK (2014) Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology 272:123–131CrossRefPubMed Davenport MS, Caoili EM, Kaza RK, Hussain HK (2014) Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology 272:123–131CrossRefPubMed
13.
Zurück zum Zitat Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS et al (2013) Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 266:452–461CrossRefPubMed Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS et al (2013) Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 266:452–461CrossRefPubMed
14.
Zurück zum Zitat Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB (2016) An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology 279:93–102CrossRefPubMed Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB (2016) An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology 279:93–102CrossRefPubMed
15.
Zurück zum Zitat Davenport MS, Bashir MR, Pietryga JA, Weber JT, Khalatbari S, Hussain HK (2014) Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol 203:796–802CrossRefPubMed Davenport MS, Bashir MR, Pietryga JA, Weber JT, Khalatbari S, Hussain HK (2014) Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol 203:796–802CrossRefPubMed
16.
Zurück zum Zitat Gutzeit A, Matoori S, Froehlich JM, von Weymarn C, Reischauer C, Kolokythas O et al (2016) Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol 26:2714–2722CrossRefPubMed Gutzeit A, Matoori S, Froehlich JM, von Weymarn C, Reischauer C, Kolokythas O et al (2016) Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol 26:2714–2722CrossRefPubMed
17.
Zurück zum Zitat Luetkens JA, Kupczyk PA, Doerner J, Fimmers R, Willinek WA, Schild HH et al (2015) Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol. Eur Radiol 25:3207–3213CrossRefPubMed Luetkens JA, Kupczyk PA, Doerner J, Fimmers R, Willinek WA, Schild HH et al (2015) Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol. Eur Radiol 25:3207–3213CrossRefPubMed
18.
Zurück zum Zitat Kim YK, Kim CS, Han YM, Park G (2010) Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45:740–746CrossRefPubMed Kim YK, Kim CS, Han YM, Park G (2010) Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45:740–746CrossRefPubMed
19.
Zurück zum Zitat Bashir MR, Castelli P, Davenport MS, Larson D, Marin D, Hussain HK et al (2015) Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology 274:141–148CrossRefPubMed Bashir MR, Castelli P, Davenport MS, Larson D, Marin D, Hussain HK et al (2015) Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology 274:141–148CrossRefPubMed
21.
Zurück zum Zitat Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR (2014) Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology 271:426–434CrossRefPubMed Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR (2014) Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology 271:426–434CrossRefPubMed
22.
Zurück zum Zitat Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC et al (2015) Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol 204:1220–1227CrossRefPubMed Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC et al (2015) Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol 204:1220–1227CrossRefPubMed
23.
Zurück zum Zitat Donner A, Eliasziw M (1987) Sample size requirements for reliability studies. Stat Med 6:441–448CrossRefPubMed Donner A, Eliasziw M (1987) Sample size requirements for reliability studies. Stat Med 6:441–448CrossRefPubMed
24.
Zurück zum Zitat Chen DS (1993) Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 8:470–475CrossRefPubMed Chen DS (1993) Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 8:470–475CrossRefPubMed
25.
Zurück zum Zitat Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11:369–376PubMed Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11:369–376PubMed
26.
Zurück zum Zitat Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN et al (2011) Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 29:3643–3650CrossRefPubMedPubMedCentral Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN et al (2011) Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 29:3643–3650CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Holland AE, Goldfarb JW, Edelman RR (1998) Diaphragmatic and cardiac motion during suspended breathing: preliminary experience and implications for breath-hold MR imaging. Radiology 209:483–489CrossRefPubMed Holland AE, Goldfarb JW, Edelman RR (1998) Diaphragmatic and cardiac motion during suspended breathing: preliminary experience and implications for breath-hold MR imaging. Radiology 209:483–489CrossRefPubMed
Metadaten
Titel
Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method
verfasst von
Ji Soo Song
Eun Jung Choi
Eun Hae Park
Ju-Hyung Lee
Publikationsdatum
06.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 3/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5070-y

Weitere Artikel der Ausgabe 3/2018

European Radiology 3/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.